1. Home
  2. NBIX vs ASND Comparison

NBIX vs ASND Comparison

Compare NBIX & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$172.01

Market Cap

13.2B

Sector

Health Care

ML Signal

HOLD

Logo Ascendis Pharma A/S

ASND

Ascendis Pharma A/S

HOLD

Current Price

$260.74

Market Cap

15.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NBIX
ASND
Founded
1992
2006
Country
United States
Denmark
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.2B
15.2B
IPO Year
1996
2014

Fundamental Metrics

Financial Performance
Metric
NBIX
ASND
Price
$172.01
$260.74
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
22
16
Target Price
$180.91
$281.50
AVG Volume (30 Days)
1.1M
704.2K
Earning Date
05-05-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
41.95
N/A
EPS
1.91
N/A
Revenue
$161,626,000.00
N/A
Revenue This Year
$24.73
$96.35
Revenue Next Year
$13.14
$44.91
P/E Ratio
$89.54
N/A
Revenue Growth
977.51
N/A
52 Week Low
$122.14
$161.09
52 Week High
$181.18
$282.15

Technical Indicators

Market Signals
Indicator
NBIX
ASND
Relative Strength Index (RSI) 56.82 55.04
Support Level $153.96 $213.28
Resistance Level N/A $282.15
Average True Range (ATR) 4.57 8.03
MACD -0.61 -0.92
Stochastic Oscillator 49.24 15.77

Price Performance

Historical Comparison
NBIX
ASND

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

About ASND Ascendis Pharma A/S

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.

Share on Social Networks: